These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 37064559
1. Debulking plus drug-coated balloon angioplasty versus drug-coated balloon angioplasty alone for femoropopliteal Tosaka III in-stent restenosis lesions. Li L, Tong Z, Cui S, Guo L. Wideochir Inne Tech Maloinwazyjne; 2023 Mar; 18(1):166-172. PubMed ID: 37064559 [Abstract] [Full Text] [Related]
2. Turbo-Power™ Laser Atherectomy Combined with Drug-coated Balloon Angioplasty is Associated with Improved One-Year Outcomes for the Treatment of Tosaka II and III Femoropopliteal In-stent Restenosis. Giannopoulos S, Kokkinidis DG, Jawaid O, Behan S, Hossain P, Alvandi B, Foley TR, Singh GD, Waldo SW, Armstrong EJ. Cardiovasc Revasc Med; 2020 Jun; 21(6):771-778. PubMed ID: 31761634 [Abstract] [Full Text] [Related]
7. Percutaneous Mechanical Atherectomy Plus Thrombectomy Using the Rotarex®S Device Followed by a Drug-Coated Balloon for the Treatment of Femoropopliteal Artery In-stent Restenosis: A Prospective Single-Center, Single-Arm Efficacy Trial (PERMIT-ISR Trial). Liu MY, Li W, Guo X, Zhang Z, Liu B, Yu H, Zhang Z, Chen X, Feng H. Front Surg; 2021 Jun; 8():671849. PubMed ID: 34595204 [Abstract] [Full Text] [Related]
8. A systematic review and meta-analysis of the efficacy of debulking devices for in-stent restenosis of the femoropopliteal artery. Li X, Zhou M, Ding Y, Wang Y, Cai L, Shi Z. J Vasc Surg; 2020 Jul; 72(1):356-366.e5. PubMed ID: 32093910 [Abstract] [Full Text] [Related]
10. The safety and efficacy of different endovascular treatments for in-stent restenosis of the femoropopliteal artery: A network meta-analysis. He Z, Wang H, Lin F, Ding W, Chen K, Zhang Z. Vasc Med; 2022 Jun; 27(3):239-250. PubMed ID: 35164613 [Abstract] [Full Text] [Related]
12. Stand-Alone Rotational Atherectomy Versus Combination With Drug-Coated Balloon Angioplasty for the Endovascular Treatment of Heavily-Calcified Femoropopliteal and Popliteal Lesions. Kronlage M, Bertele M, Linden F, Frey N, Erbel C. J Endovasc Ther; 2023 Dec 26; ():15266028231219663. PubMed ID: 38146867 [Abstract] [Full Text] [Related]
15. Efficacy and safety of adjunctive drug-coated balloon therapy in endovascular treatment of common femoral artery disease. Imran HM, Hyder ON, Soukas PA. Cardiovasc Revasc Med; 2019 Mar 26; 20(3):210-214. PubMed ID: 29970328 [Abstract] [Full Text] [Related]
16. The role for DCBs in the treatment of ISR. Bague N, Nasr B, Chaillou P, Costargent A, Gouailler-Vulcain F, Goueffic Y. J Cardiovasc Surg (Torino); 2016 Aug 26; 57(4):578-85. PubMed ID: 27102629 [Abstract] [Full Text] [Related]
17. Long-term outcomes with Jetstream atherectomy with or without drug coated balloons in treating femoropopliteal arteries: A single center experience (JET-SCE). Shammas NW, Shammas GA, Jones-Miller S, Shammas WJ, Bou-Dargham B, Shammas AN, Banerjee S, Rachwan RJ, Daher GE. Cardiovasc Revasc Med; 2018 Oct 26; 19(7 Pt A):771-777. PubMed ID: 30420096 [Abstract] [Full Text] [Related]
19. [Mid- and long-term outcomes and prognostic factors of drug-coated balloon angioplasty for treatment of femoropopliteal long lesions]. Cao ZJ, Zhang T, Zhao KQ, Zhao JL, Yu XH, Li YW, Wu WW. Zhonghua Wai Ke Za Zhi; 2022 Jan 01; 60(1):57-62. PubMed ID: 34954948 [Abstract] [Full Text] [Related]